MARKET

NKGNW

NKGNW

NKGen Biotech
OTCPK
0.035
NaN%
Closed 09:30 05/13 EDT
OPEN
--
PREV CLOSE
0.035
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.248
52 WEEK LOW
0.020
MARKET CAP
--
P/E (TTM)
-0.0169
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NKGNW last week (0505-0509)?
Weekly Report · 1d ago
Weekly Report: what happened at NKGNW last week (0428-0502)?
Weekly Report · 05/05 11:20
Weekly Report: what happened at NKGNW last week (0421-0425)?
Weekly Report · 04/28 11:30
Weekly Report: what happened at NKGNW last week (0414-0418)?
Weekly Report · 04/21 11:29
Weekly Report: what happened at NKGNW last week (0407-0411)?
Weekly Report · 04/14 11:18
Weekly Report: what happened at NKGNW last week (0331-0404)?
Weekly Report · 04/07 11:18
Weekly Report: what happened at NKGNW last week (0324-0328)?
Weekly Report · 03/31 11:30
Weekly Report: what happened at NKGNW last week (0317-0321)?
Weekly Report · 03/24 11:17
More
About NKGNW
NKGen Biotech, Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapeutics. Its product candidates are based on a manufacturing and cryopreservation process, which produces SuperNK (SNK) cells. SNK cells can be produced in large quantities and cryopreserved, while maintaining high levels of cytotoxicity and activating receptor expression after thawing and reconstitution. It is developing SNK01, an autologous natural killer (NK) cell therapy, for the treatment of neurodegenerative diseases, including Alzheimer’s disease (AD) and Parkinson’s disease (PD). Its autologous NK cell therapy candidate has clinical trials in several therapeutic areas, including oncology and neurodegeneration. SNK02 is its allogeneic NK cell product candidate. It is conducting clinical trials with its SNK cell therapy in patients with neurodegenerative disease (SNK01) and cancer (SNK02).

Webull offers NKGen Biotech Inc stock information, including OTCPK: NKGNW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NKGNW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NKGNW stock methods without spending real money on the virtual paper trading platform.